An end to end set of modules, in one single platform, dedicated to real world late phase studies.
Book a demoIndustry leading EDC, eConsent, ePRO and eCOA functionality for real world late phase studies
Our highly flexible, fully integrated platform provides you with a complete set of tools and workflows, designed specifically by late phase experts to meet the unique and diverse late phase real world landscape. Baseline Plus contains, EDC, ePRO, eConsent , eDiary, Registry and Managed/Early access programme modules, removing the need to introduce physicians and patients to a variety of systems with different functionality. Our platform contains everything you need to run your late phase clinical study, helping you to deliver rapid study builds, more efficiently, and with better data, faster.
Designed specifically for the diverse nature of late phase studies, the EDC platform is easy to use and requires little training, which supports users naïve to studies and the often infrequent nature of data capture. In late phase studies there can be low levels of source data verification and monitoring and therefore the EDC platform has in built edit checks to ensure data quality is of a high standard.
Baseline Plus provides a flexible multi modal eConsent that support remote and at site consent workflows. The eConsent is fully integrated with Baseline Plus real world EDC, ePRO and patient sourced data. Highly configurable through Baseline Designer and 21 CFR Part 11compliant. The eConsent module can be run on a browser, app or tablet.
Our eCOA module allows study investigators to collect data from a variety of stakeholders using different platforms. The module has a single point of design which allows for easy data capture for both the site and patients, stored in a single database controlled by role-based access. Data can be shared between sites and patients where necessary and the module is fully compliant with GDPR and HIPAA regulations.
Our ePRO module allows study investigators to collect data direct patients through bring your own device, phone, app or web browser options. The module is easy to use and removes the need for introducing patients to a variety of different platforms. The module is fully compliant with GDPR and HIPAA regulations.
Collaborating with 90% of the top global pharmaceutical companies
Over 200 studies delivered in the last 4 years
Proven to reduce data management costs by over 60%